Evidence map›Paper›PMID 35187380›Full record

ArticlePain reports

The neurologic pain signature responds to nonsteroidal anti-inflammatory treatment vs placebo in knee osteoarthritis.

Marina López-Solà, Jesus Pujol, Jordi Monfort, Joan Deus, Laura Blanco-Hinojo, Ben J Harrison, Tor D Wager

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Pain reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05986513 (Investigating Brain Abnormalities in People With Knee Osteoarthritis Using MRI), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05986513 naunknown statusnot on this map

Investigating Brain Abnormalities in People With Knee Osteoarthritis Using MRI: a Nociplastic Pain Mechanism Based Assessment

TypeinterventionalSponsorToronto Rehabilitation InstituteRan2023 to 2025Enrolled66ConditionsChronic Pain, Central Sensitisation, Knee OsteoarthritisArmsCold Pressor Gel Test
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Ketamine-induced analgesia and dissociation show distinct behavioral and neural correlates.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Marina López-SolàDepartment of Medicine, School of Medicine and Health Sciences, Serra Hunter Faculty Program, University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0002-5517-2665
Jesus PujolMRI Research Unit, Department of Radiology, Hospital del Mar, Barcelona, Spain.
Jordi MonfortRheumatology Department, Hospital del Mar, Barcelona, Spain.
Joan DeusMRI Research Unit, Department of Radiology, Hospital del Mar, Barcelona, Spain.
Laura Blanco-HinojoMRI Research Unit, Department of Radiology, Hospital del Mar, Barcelona, Spain.
Ben J HarrisonDepartment of Psychiatry, Melbourne Neuropsychiatry Centre, The University of Melbourne & Melbourne Health, Melbourne, Australia.
Tor D WagerDepartment of Psychological and Brain Sciences, Dartmouth College, Dartmouth, MA, USA.
Centro de Investigación Biomédica en Red de Salud Mental · ESDartmouth College · USHospital Del Mar · ESThe University of Melbourne · AUUniversitat Autònoma de Barcelona · ESUniversitat de Barcelona · ES

Funding

The Neural Bases of Placebo Effects and their Relation to Regulatory ProcessesR01MH076136 · NIMH · UNIVERSITY OF COLORADO · PI WAGER, TOR D. · 2007 to 2023
$8.5M
fMRI-based Biomarkers for Multiple Components of PainR01DA035484 · NIDA · UNIVERSITY OF COLORADO · PI WAGER, TOR D. · 2013 to 2017
$3.1M
NIDA NIH HHS R01 DA035484NIMH NIH HHS R01 MH076136
6 · The paper itself

Abstract

introductionMany drug trials for chronic pain fail because of high placebo response rates in primary endpoints. Neurophysiological measures can help identify pain-linked pathophysiology and treatment mechanisms. They can also help guide early stop/go decisions, particularly if they respond to verum treatment but not placebo. The neurologic pain signature (NPS), an fMRI-based measure that tracks evoked pain in 40 published samples and is insensitive to placebo in healthy adults, provides a potentially useful neurophysiological measure linked to nociceptive pain.

objectivesThis study aims to validate the NPS in knee osteoarthritis (OA) patients and test the effects of naproxen on this signature.

methodsIn 2 studies (50 patients, 64.6 years, 75% females), we (1) test the NPS and other control signatures related to negative emotion in knee OA pain patients; (2) test the effect of placebo treatments; and (3) test the effect of naproxen, a routinely prescribed nonsteroidal anti-inflammatory drug in OA.

resultsThe NPS was activated during knee pain in OA (

conclusionThis study provides preliminary evidence that fMRI-based measures, validated for nociceptive pain, respond to acute OA pain, do not appear sensitive to placebo, and are mild-to-moderately sensitive to naproxen.

Indexed as

Chronic painfMRINeurologic pain signatureNSAIDOsteoarthritisPlacebo

Identifiers

PMID35187380
PMCPMC8853614
OpenAlexW4212765843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.